Steimer D, Tramontozzi P, Gedeon P, Pommerening M, DeSimone A, Bueno R
Ann Thorac Surg Short Rep. 2024; 2(4):613-617.
PMID: 39737220
PMC: 11684418.
DOI: 10.1016/j.atssr.2024.06.024.
Omura K, Fukai R, Nishida T, Yamaguchi N, Naitoh W, Teshima S
Gen Thorac Cardiovasc Surg Cases. 2024; 2(1):57.
PMID: 39517014
PMC: 11533526.
DOI: 10.1186/s44215-023-00077-8.
Gill R, Nowak A, Giroux D, Eisele M, Rosenthal A, Kindler H
J Thorac Oncol. 2024; 19(9):1310-1325.
PMID: 38521202
PMC: 11380601.
DOI: 10.1016/j.jtho.2024.03.007.
Chen Y, Du X, Gao Y, Wu H, Zhao H, Su Y
Cancer Control. 2023; 30:10732748231220805.
PMID: 38092371
PMC: 10722924.
DOI: 10.1177/10732748231220805.
Song J, Nam B, Yoon S, Yoo J, Jeong Y, Yeo C
Taehan Yongsang Uihakhoe Chi. 2022; 82(3):562-574.
PMID: 36238776
PMC: 9432450.
DOI: 10.3348/jksr.2020.0185.
Polyphenol Extract from Evening Primrose () Inhibits Invasion Properties of Human Malignant Pleural Mesothelioma Cells.
Chmielewska-Kassassir M, Sobierajska K, Ciszewski W, Bukowiecka-Matusiak M, Szczesna D, Burzynska-Pedziwiatr I
Biomolecules. 2020; 10(11).
PMID: 33228230
PMC: 7699585.
DOI: 10.3390/biom10111574.
Survival analysis via nomogram of surgical patients with malignant pleural mesothelioma in the Surveillance, Epidemiology, and End Results database.
Zhuo M, Zheng Q, Chi Y, Jia B, Zhao J, Wu M
Thorac Cancer. 2019; 10(5):1193-1202.
PMID: 30951250
PMC: 6501014.
DOI: 10.1111/1759-7714.13063.
Proton beam therapy for malignant pleural mesothelioma.
Badiyan S, Molitoris J, Zhu M, Glass E, Diwanji T, Simone 2nd C
Transl Lung Cancer Res. 2018; 7(2):189-198.
PMID: 29876318
PMC: 5960661.
DOI: 10.21037/tlcr.2018.04.07.
Intensity-Modulated Radiation Therapy Improves the Target Coverage Over 3-D Planning While Meeting Lung Tolerance Doses for All Patients With Malignant Pleural Mesothelioma.
Ulger S, Cetin E, Catli S, Sarac H, Kilic D, Bora H
Technol Cancer Res Treat. 2017; 16(3):332-338.
PMID: 28462689
PMC: 5616048.
DOI: 10.1177/1533034616678110.
Malignant mesothelioma of the pleura with desmoplastic histology: a case series and literature review.
Hashimoto K, Okuma Y, Hosomi Y, Hishima T
BMC Cancer. 2016; 16:718.
PMID: 27599565
PMC: 5012075.
DOI: 10.1186/s12885-016-2745-8.
Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial.
Clive A, Taylor H, Dobson L, Wilson P, De Winton E, Panakis N
Lancet Oncol. 2016; 17(8):1094-1104.
PMID: 27345639
PMC: 4961873.
DOI: 10.1016/S1470-2045(16)30095-X.
Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis.
Micolucci L, Akhtar M, Olivieri F, Rippo M, Procopio A
Oncotarget. 2016; 7(36):58606-58637.
PMID: 27259231
PMC: 5295457.
DOI: 10.18632/oncotarget.9686.
Impact of Age on Long-Term Outcomes of Surgery for Malignant Pleural Mesothelioma.
Yang C, Yan B, Meyerhoff R, Saud S, Gulack B, Speicher P
Clin Lung Cancer. 2016; 17(5):419-426.
PMID: 27236386
PMC: 5026893.
DOI: 10.1016/j.cllc.2016.03.002.
Inhibition of FGF/FGFR autocrine signaling in mesothelioma with the FGF ligand trap, FP-1039/GSK3052230.
Blackwell C, Sherk C, Fricko M, Ganji G, Barnette M, Hoang B
Oncotarget. 2016; 7(26):39861-39871.
PMID: 27223434
PMC: 5129976.
DOI: 10.18632/oncotarget.9515.
Retrospective analysis of unknown primary cancers with malignant pleural effusion at initial diagnosis.
Ebata T, Okuma Y, Nakahara Y, Yomota M, Takagi Y, Hosomi Y
Thorac Cancer. 2016; 7(1):39-43.
PMID: 26816537
PMC: 4718124.
DOI: 10.1111/1759-7714.12271.
Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database.
Meyerhoff R, Yang C, Speicher P, Gulack B, Hartwig M, DAmico T
J Surg Res. 2015; 196(1):23-32.
PMID: 25791825
PMC: 4430361.
DOI: 10.1016/j.jss.2015.01.043.
Management of malignant pleural mesothelioma-The European experience.
Opitz I
J Thorac Dis. 2014; 6 Suppl 2:S238-52.
PMID: 24868442
PMC: 4032963.
DOI: 10.3978/j.issn.2072-1439.2014.05.03.
Extrapleural pneumonectomy or pleurectomy/decortication for malignant pleural mesothelioma.
Hasegawa S
Gen Thorac Cardiovasc Surg. 2014; 62(9):516-21.
PMID: 24639000
PMC: 4153961.
DOI: 10.1007/s11748-014-0389-7.
Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.
van Zandwijk N, Clarke C, Henderson D, William Musk A, Fong K, Nowak A
J Thorac Dis. 2014; 5(6):E254-307.
PMID: 24416529
PMC: 3886874.
DOI: 10.3978/j.issn.2072-1439.2013.11.28.
Clinical practice guidelines for malignant pleural mesothelioma.
van Zandwijk N
J Thorac Dis. 2014; 5(6):724-5.
PMID: 24409346
PMC: 3886699.
DOI: 10.3978/j.issn.2072-1439.2013.12.50.
